S2 Genomics Inks Canadian Distribution Deal With D-Mark Bioscences

Oct 28, 2020

|

NEW YORK – S2 Genomics has entered into a distribution agreement with D-Mark Biosciences in Canada for the promotion, sale, and support of S2's Singulator 100 system and associated products for single-cell genomics and cell biology applications.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

Menu

S2 Genomics Inks Canadian Distribution Deal With D-Mark Bioscences

To read the full story....

Breaking News

Epigenome Study Maps Hydroxymethylation Across Diverse Human Tissue Types

Twist Bioscience Proposes $250M Public Offering

CDC Advises Avoiding Holiday Travel, Using SARS-CoV-2 Testing to Mitigate Risk During COVID-19 Surge

China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

Nonalcoholic Fatty Liver Disease Progression Can Be Traced by Gene Expression Signature

Depression-Related Gut Microbiome, Metabolite Changes Lead to Potential Biomarker Set

The Scan

Vaccine Authorization

Healthcare Workers, Nursing Home Residents First

Hackers Target Vaccine Makers

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

What's Popular?

Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents

Twist Bioscience Proposes $250M Public Offering

NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022

Thermo Fisher Scientific Raises Q4 and 2020 Revenue, Earnings Guidance

Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

Sponsorships